DL has served as a consultant for Zealand Pharma A/S, Crinetics Pharmaceuticals, Hanmi Pharmaceutical, Heptares Therapeutics, Poxel Pharma, Ultragenyx, and Eiger Pharma
Here are some examples of out-of-pocket costs for one-month supplies of non-generic psychotropic medications (prices accurate as of November 2025 per GoodRx): Viibryd: $439.67 Trintellex: $622.77 Vraylar: $1823.11 Caplyta: $2053.00 Qelbree: $454.37 JornayPM: $568.98 These costs remain out of reach for many patientshighlighting the urgent need for price reform
Hair restoration With decreased DHT levels, hair follicles can recover, promoting hair growth in affected areas
It remains an investigational compound in Phase 3 clinical development
Is this only for wealthy people? We work with patients across all budgets
This includes any possible side effects not listed in the product information